COMMENTOzempic compensating for Wegovy’s supply shortage due to high demand Manufacturing challenges set back progress of cell therapies in oncologyChinese manufacturers’ transition to innovative pharma needs more investmentDLBCL: a rapidly evolving treatment landscape with a crowded pipeline R&DCannabinoids receptors: popular preclinical target but banned in 137 countriesCannabinoid receptors are currently the most popular targets for CNS in preclinical development, with 391 drugs tagged in totalinsightEurope reports the highest prevalence of chronic coughcommentCould vaccine hesitancy impact hearing disorders?Ozempic compensating for Wegovy’s supply shortage due to high demandManufacturing challenges set back progress of cell therapies in oncologyChinese manufacturers’ transition to innovative pharma needs more investmentDLBCL: a rapidly evolving treatment landscape with a crowded pipeline02/23/2024 23:26:12
Ozempic compensating for Wegovy’s supply shortage due to high demand
Manufacturing challenges set back progress of cell therapies in oncology
Chinese manufacturers’ transition to innovative pharma needs more investment
DLBCL: a rapidly evolving treatment landscape with a crowded pipeline